Showing posts with label Astronics. Show all posts
Showing posts with label Astronics. Show all posts

Tuesday, May 17, 2011

Coverage on (AMAP) (ANTH) (ATRO) (CLDX) (CTAS) Initiated

Coverage on AutoNavi Holdings Ltd (NASDAQ: AMAP), Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), Astronics Co. (NASDAQ: ATRO), Celldex Therapeutics Inc (NASDAQ: CLDX) and Cintas (NASDAQ: CTAS) was initiated by analysts.

Deutsche Bank (NYSE:DB) initiated coverage on AutoNavi Holdings Ltd (AMAP). They placed a “buy” rating and a price target of $22.00 on the company.

Leerink initiated coverage on Anthera Pharmaceuticals, Inc. (ANTH). They placed an “outperform” rating on the company.

EarlyBird Capital initiated coverage on Astronics Co. (ATRO). They placed a “hold” rating on the company.

Oppenheimer initiated coverage on Celldex Therapeutics Inc (CLDX). They placed an “outperform” rating and a price target of $6.00 on the company.

Stifel Nicolaus initiated coverage on Cintas (CTAS). They placed a “hold” rating and a price target of $30.70 on the company.

Wednesday, April 27, 2011

Astronics (ATRO) (AH) (CSOD) (CYOU) - New Ratings and Price Targets

New ratings and price targets on Astronics Co. (NASDAQ: ATRO), Accretive Health, Inc. (NYSE: AH), Cornerstone OnDemand (NASDAQ: CSOD) and Changyou.com Ltd (NASDAQ: CYOU).

Oppenheimer initiated coverage on Accretive Health, Inc. (AH). They placed a “Perform” rating on the firm.

Pacific Crest initiated coverage on Cornerstone OnDemand (CSOD). They placed an “Outperform” rating and a price target of $23.00 on the company.

Capstone initiated coverage on Astronics Co. (ATRO). They placed a “Buy” rating on the stock.

Brean Murray initiated coverage on Changyou.com Ltd (CYOU). They placed a “Buy” rating and a price target of $53.00 on them.